Ondine Short Long Term Debt Total vs Non Current Liabilities Total Analysis

OBI Stock

12.00 0.25 2.04%

Ondine Biomedical financial indicator trend analysis is much more than just breaking down Ondine Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ondine Biomedical is a good investment. Please check the relationship between Ondine Biomedical Short Long Term Debt Total and its Non Current Liabilities Total accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Short Long Term Debt Total vs Non Current Liabilities Total

Short Long Term Debt Total vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ondine Biomedical Short Long Term Debt Total account and Non Current Liabilities Total. At this time, the significance of the direction appears to have weak relationship.

The correlation between Ondine Biomedical's Short Long Term Debt Total and Non Current Liabilities Total is 0.3. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Ondine Biomedical, assuming nothing else is changed. The correlation between historical values of Ondine Biomedical's Short Long Term Debt Total and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Ondine Biomedical are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Short Long Term Debt Total i.e., Ondine Biomedical's Short Long Term Debt Total and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.3

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Short Long Term Debt Total

Non Current Liabilities Total

Most indicators from Ondine Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ondine Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

As of February 16, 2025, Selling General Administrative is expected to decline to about 7.8 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 4.2 M

	2022	2023	2024	2025 (projected)
Interest Expense	30K	38K	34.2K	32.5K
Depreciation And Amortization	493K	587K	528.3K	517.3K

Interest Expense Depreciation And Amortization

Ondine Biomedical fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Other Current Assets	Short Term Debt	Inventory	Intangible Assets	Short Term Investments	Capital Surpluse	Common Stock
Total Assets		-0.38	0.78	0.28	-0.8	-0.49	0.41	1.0	-0.43	-0.21	1.0	0.23	-0.27	-0.08	0.39	-0.36	1.0	-0.43	0.32	0.89	-0.43	0.58	-0.31	-0.2	0.17	0.52
Total Current Liabilities	-0.38		-0.87	-0.17	0.85	0.1	-0.5	-0.36	0.15	-0.31	-0.37	0.24	0.31	0.29	-0.04	1.0	-0.38	0.99	0.29	-0.24	0.99	-0.45	0.21	-0.34	0.34	-0.44
Total Stockholder Equity	0.78	-0.87		0.24	-0.99	-0.31	0.55	0.77	-0.31	0.1	0.78	-0.07	-0.37	-0.23	0.2	-0.86	0.78	-0.89	-0.04	0.62	-0.89	0.61	-0.29	0.12	-0.12	0.54
Property Plant And Equipment Net	0.28	-0.17	0.24		-0.33	-0.71	0.32	0.32	-0.76	-0.07	0.33	0.47	0.11	-0.14	0.82	-0.14	0.35	-0.24	0.63	0.32	-0.25	0.63	-0.81	-0.1	0.11	0.69
Net Debt	-0.8	0.85	-0.99	-0.33		0.37	-0.57	-0.79	0.41	-0.1	-0.8	-0.04	0.36	0.24	-0.3	0.84	-0.8	0.88	-0.06	-0.67	0.88	-0.64	0.38	-0.11	0.12	-0.6
Retained Earnings	-0.49	0.1	-0.31	-0.71	0.37		-0.68	-0.47	0.54	0.66	-0.48	-0.56	-0.52	0.03	-0.89	0.09	-0.52	0.2	-0.64	-0.64	0.21	-0.83	0.45	0.64	-0.59	-0.89
Accounts Payable	0.41	-0.5	0.55	0.32	-0.57	-0.68		0.38	-0.37	-0.38	0.39	0.28	0.26	-0.13	0.56	-0.5	0.43	-0.56	0.16	0.56	-0.57	0.73	-0.26	-0.4	0.4	0.79
Cash	1.0	-0.36	0.77	0.32	-0.79	-0.47	0.38		-0.49	-0.15	1.0	0.26	-0.33	-0.07	0.41	-0.34	1.0	-0.41	0.35	0.89	-0.42	0.56	-0.38	-0.14	0.13	0.5
Non Current Assets Total	-0.43	0.15	-0.31	-0.76	0.41	0.54	-0.37	-0.49		-0.18	-0.5	-0.73	0.27	0.04	-0.8	0.13	-0.51	0.23	-0.61	-0.6	0.24	-0.34	0.97	-0.18	0.18	-0.6
Non Currrent Assets Other	-0.21	-0.31	0.1	-0.07	-0.1	0.66	-0.38	-0.15	-0.18		-0.15	-0.21	-0.83	-0.06	-0.37	-0.32	-0.18	-0.26	-0.35	-0.33	-0.25	-0.51	-0.32	0.98	-0.91	-0.41
Cash And Short Term Investments	1.0	-0.37	0.78	0.33	-0.8	-0.48	0.39	1.0	-0.5	-0.15		0.27	-0.32	-0.08	0.42	-0.35	1.0	-0.42	0.35	0.9	-0.42	0.56	-0.39	-0.14	0.12	0.52
Net Receivables	0.23	0.24	-0.07	0.47	-0.04	-0.56	0.28	0.26	-0.73	-0.21	0.27		0.14	-0.12	0.76	0.26	0.3	0.13	0.83	0.56	0.13	0.2	-0.63	-0.18	0.14	0.47
Common Stock Shares Outstanding	-0.27	0.31	-0.37	0.11	0.36	-0.52	0.26	-0.33	0.27	-0.83	-0.32	0.14		0.06	0.33	0.3	-0.28	0.26	0.22	-0.09	0.26	0.32	0.3	-0.78	0.71	0.36
Non Current Liabilities Total	-0.08	0.29	-0.23	-0.14	0.24	0.03	-0.13	-0.07	0.04	-0.06	-0.08	-0.12	0.06		-0.04	0.29	-0.08	0.3	-0.01	-0.08	0.3	-0.12	0.09	-0.08	0.08	-0.12
Other Stockholder Equity	0.39	-0.04	0.2	0.82	-0.3	-0.89	0.56	0.41	-0.8	-0.37	0.42	0.76	0.33	-0.04		-0.01	0.46	-0.14	0.72	0.63	-0.15	0.62	-0.75	-0.35	0.29	0.87
Total Liab	-0.36	1.0	-0.86	-0.14	0.84	0.09	-0.5	-0.34	0.13	-0.32	-0.35	0.26	0.3	0.29	-0.01		-0.36	0.99	0.31	-0.23	0.99	-0.44	0.19	-0.34	0.34	-0.42
Total Current Assets	1.0	-0.38	0.78	0.35	-0.8	-0.52	0.43	1.0	-0.51	-0.18	1.0	0.3	-0.28	-0.08	0.46	-0.36		-0.43	0.37	0.91	-0.43	0.59	-0.4	-0.17	0.15	0.56
Short Long Term Debt Total	-0.43	0.99	-0.89	-0.24	0.88	0.2	-0.56	-0.41	0.23	-0.26	-0.42	0.13	0.26	0.3	-0.14	0.99	-0.43		0.18	-0.32	1.0	-0.52	0.28	-0.28	0.29	-0.53
Other Current Liab	0.32	0.29	-0.04	0.63	-0.06	-0.64	0.16	0.35	-0.61	-0.35	0.35	0.83	0.22	-0.01	0.72	0.31	0.37	0.18		0.46	0.17	0.46	-0.53	-0.39	0.39	0.43
Other Current Assets	0.89	-0.24	0.62	0.32	-0.67	-0.64	0.56	0.89	-0.6	-0.33	0.9	0.56	-0.09	-0.08	0.63	-0.23	0.91	-0.32	0.46		-0.33	0.53	-0.45	-0.28	0.21	0.67
Short Term Debt	-0.43	0.99	-0.89	-0.25	0.88	0.21	-0.57	-0.42	0.24	-0.25	-0.42	0.13	0.26	0.3	-0.15	0.99	-0.43	1.0	0.17	-0.33		-0.53	0.29	-0.28	0.28	-0.54
Inventory	0.58	-0.45	0.61	0.63	-0.64	-0.83	0.73	0.56	-0.34	-0.51	0.56	0.2	0.32	-0.12	0.62	-0.44	0.59	-0.52	0.46	0.53	-0.53		-0.28	-0.55	0.57	0.8
Intangible Assets	-0.31	0.21	-0.29	-0.81	0.38	0.45	-0.26	-0.38	0.97	-0.32	-0.39	-0.63	0.3	0.09	-0.75	0.19	-0.4	0.28	-0.53	-0.45	0.29	-0.28		-0.32	0.32	-0.56
Short Term Investments	-0.2	-0.34	0.12	-0.1	-0.11	0.64	-0.4	-0.14	-0.18	0.98	-0.14	-0.18	-0.78	-0.08	-0.35	-0.34	-0.17	-0.28	-0.39	-0.28	-0.28	-0.55	-0.32		-0.98	-0.36
Capital Surpluse	0.17	0.34	-0.12	0.11	0.12	-0.59	0.4	0.13	0.18	-0.91	0.12	0.14	0.71	0.08	0.29	0.34	0.15	0.29	0.39	0.21	0.28	0.57	0.32	-0.98		0.29
Common Stock	0.52	-0.44	0.54	0.69	-0.6	-0.89	0.79	0.5	-0.6	-0.41	0.52	0.47	0.36	-0.12	0.87	-0.42	0.56	-0.53	0.43	0.67	-0.54	0.8	-0.56	-0.36	0.29

Click cells to compare fundamentals

Ondine Biomedical Account Relationship Matchups

Ondine Biomedical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.6M	34.1M	16.6M	5.7M	6.6M	9.0M
Total Current Liabilities	35.8M	3.9M	3.9M	3.5M	4.0M	3.8M
Total Stockholder Equity	(33.8M)	29.7M	11.6M	2.1M	1.9M	2.0M
Property Plant And Equipment Net	671K	601K	1.4M	949K	1.1M	663.6K
Net Debt	30.8M	(29.6M)	(12.2M)	(2.4M)	(2.8M)	(2.7M)
Retained Earnings	(182.1M)	(232.5M)	(251.9M)	(266.3M)	(239.7M)	(227.7M)
Accounts Payable	237K	1.2M	388K	1.4M	1.6M	923.0K
Cash	626K	30.4M	13.1M	3.0M	3.4M	4.5M
Non Current Assets Total	888K	636K	1.4M	984K	1.1M	1.3M
Non Currrent Assets Other	40K	46K	35K	36K	31.5K	29.9K
Cash And Short Term Investments	626K	30.4M	13.1M	3.0M	3.4M	5.6M
Net Receivables	543K	248K	133K	220K	198K	269.6K
Liabilities And Stockholders Equity	2.6M	34.1M	16.6M	5.7M	6.6M	9.0M
Non Current Liabilities Total	678K	561K	1.0M	159K	182.9K	173.7K
Other Stockholder Equity	28.8M	27.2M	28.5M	28.8M	33.1M	33.0M
Total Liab	36.5M	4.5M	4.9M	3.6M	4.2M	4.0M
Total Current Assets	1.7M	33.5M	15.1M	4.8M	5.5M	7.7M
Short Long Term Debt Total	31.5M	739K	896K	541K	622.2K	591.0K
Other Current Liab	4.2M	2.1M	3.2M	1.7M	2.0M	1.0M
Other Current Assets	717K	2.1M	710K	703K	632.7K	1.1M
Short Term Debt	31.4M	645K	359K	382K	439.3K	417.3K
Inventory	404K	1.1M	1.3M	1.1M	1.2M	646.2K
Capital Lease Obligations	310K	242K	896K	541K	622.2K	469.7K
Net Invested Capital	334K	30.2M	11.6M	2.1M	2.4M	2.3M
Net Working Capital	(34.0M)	29.6M	11.2M	1.3M	1.4M	1.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Other Information on Investing in Ondine Stock

Balance Sheet is a snapshot of the financial position of Ondine Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Ondine Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ondine Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ondine currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ondine Short Long Term Debt Total vs Non Current Liabilities Total Analysis

Short Long Term Debt Total vs Non Current Liabilities Total

Short Long Term Debt Total vs Non Current Liabilities Total Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Non Current Liabilities Total

Ondine Biomedical fundamental ratios Correlations

Ondine Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ondine Biomedical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Ondine Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Net Debt	- 0.99	Total Stockholder Equity
Capital Surpluse	- 0.98	Short Term Investments
Capital Surpluse	- 0.91	Non Currrent Assets Other
Common Stock	- 0.89	Retained Earnings
Other Stockholder Equity	- 0.89	Retained Earnings
Short Term Debt	- 0.89	Total Stockholder Equity